ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

MS

Maria Sklodowska-Curie National Research Institute of Oncology at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Maria Sklodowska-Curie National Research Institute of Oncology takes part in 12 sessions at ESMO 2026 in Madrid. Its work spans breast cancer, sarcoma, melanoma, and lung cancer, with attention to treatment safety and biomarkers. Specific studies examine drug-related side effects in breast cancer and treatment approaches for early melanoma.

OrganizationESMO 2026 Attendance
MS
Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, Poland
Cancer centre & hospital
National cancer research institute and hospital in Warsaw, Poland, with branches in Kraków and Gliwice.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Real-world BRCA1/2 testing patterns in early breast cancer in the era of adjuvant CDK4/6 inhibitors
Friday Poster Display session 3
Breast cancerBiomarkers & precision oncology
Chair
Fri Oct 23
16:15–17:45
Rapid oral 1: Gastrointestinal tumour, upper digestive
with Instituto do Câncer do Estado de São Paulo (ICESP), Sun Yat-sen University Cancer Center
Gastrointestinal cancers
Abstract
Fri Oct 23
17:24–17:36
Invited Discussant 2879RO, 3136RO and 2883RO
Rapid oral 1: Gastrointestinal tumour, upper digestive
Gastrointestinal cancers
Poster
Sat Oct 24
12:00–12:45
Talk
Sat Oct 24
12:12–12:19
Table 7
Mentor the Mentor session
Satellite
Sat Oct 24
14:45–15:05
Dermatological care in EGFR-mutated NSCLC: balancing efficacy and skin tolerabilit
J&J - Collaborative Precision Care in EGFR-mutated NSCLC. A Multidisciplinary Approach
Lung & thoracic cancersNursing & supportive care
Talk
Sat Oct 24
16:30–16:45
Driving CAR T therapy: Principles, mechanisms, and roadblocks
Innovations in cancer treatment
Poster
Sun Oct 25
12:00–12:45
Chair
Sun Oct 25
14:45–16:00
More cures in early melanoma
with CHU de Besançon
Melanoma & skin cancers
Talk
Sun Oct 25
14:50–15:10
Surgery, sentinels and adjuvant approaches
More cures in early melanoma
Melanoma & skin cancers
Poster
Mon Oct 26
12:00–12:45
Detailed safety analysis of varegacestat treatment for desmoid tumors in the RINGSIDE phase 3 trial
Monday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Maria Sklodowska-Curie National Research Institute of Oncology

Tell us what you sell and we’ll find the people at Maria Sklodowska-Curie National Research Institute of Oncology most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction